These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 887460)

  • 1. [Effect of glucagon on serum immunoreactive insulin concentration in patients with compensated liver cirrhosis].
    Czekalski S; Kozak W; Eder M; Gryczyńska M; Porawska J; Kozal H
    Pol Arch Med Wewn; 1977 Jul; 58(1):17-21. PubMed ID: 887460
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of insulin and glucagon on the liver.
    Rastogi GK
    J Assoc Physicians India; 1972 Nov; 20(11):859-66. PubMed ID: 4654918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucagon mediated insulin release in man].
    Marks V; Salmols E
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():285-308. PubMed ID: 4907221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of glucagon on insulin secretion in acute viral hepatitis].
    Kiczka W; Juszczyk J; Adamek J; Kosowicz J; Porawska J
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1295-8. PubMed ID: 1161567
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated plasma glucagon levels in cirrhosis of the liver.
    Marco J; Diego J; Villanueva ML; Diaz-Fierros M; Valverde I; Segovia JM
    N Engl J Med; 1973 Nov; 289(21):1107-11. PubMed ID: 4754949
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood ammonia levels in advanced cirrhosis during therapeutic elevation of the insulin:glucagon ratio.
    Walker C; Peterson W; Unger R
    N Engl J Med; 1974 Jul; 291(4):168-71. PubMed ID: 4834486
    [No Abstract]   [Full Text] [Related]  

  • 7. [The pancreatic beta-cell in the field of current diabetology].
    Schatz H
    Acta Med Austriaca; 1974; 3(1):79-88. PubMed ID: 4377060
    [No Abstract]   [Full Text] [Related]  

  • 8. [The blood sugar raising effect of glucagon in liver cirrhosis].
    Tornóczky J; Tóth A; Balikó Z; Pasztarak E; Lovász E; Tóth G; Muth L
    Orv Hetil; 1982 Aug; 123(32):1967-71. PubMed ID: 6755341
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulsatile insulin secretion into the portal vein in liver cirrhosis].
    Storch MJ; Rössle M; Kerp L
    Dtsch Med Wochenschr; 1993 Feb; 118(5):134-8. PubMed ID: 8432232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C
    Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of some general anesthetics and surgical stress on the serum immunoreactive insulin levels].
    Malatinský J; Vigas M; Kadlic T; Neméth S
    Rozhl Chir; 1975 Dec; 54(12):814-20. PubMed ID: 1216067
    [No Abstract]   [Full Text] [Related]  

  • 12. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
    Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
    Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
    Kruszynska YT; Ghatei MA; Bloom SR; McIntyre N
    Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in plasma insulin and growth hormone after intravenous glucagon in hepatic cirrhosis].
    Ghirlanda G; Manna R; Rebuzzi A; Altomonte L; Greco AV
    Minerva Med; 1976 Oct; 67(49):3187-92. PubMed ID: 995278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
    Gragnoli G; Signorini AM; Tanganelli I
    J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenosine triphosphate (ATP) and glucose. Action on insulin and glucagon secretion].
    Loubatières-Mariani MM; Loubatières AL; Chapal J; Valette G
    C R Seances Soc Biol Fil; 1976; 170(4):833-6. PubMed ID: 137051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin releasing activity of oral L-tryptophan in fasting and non-fasting subjects.
    Ajdukiewicz AB; Keane P; Pearson J; Read AE; Salmon PR
    Scand J Gastroenterol; 1968; 3(6):622-4. PubMed ID: 4893732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Decrease of glucose tolerance and insulin secretion after infusion with ammonium salts in normal humans and patients with fatty liver or liver cirrhosis].
    Schlienger JL; Imler M; Stahl J
    Biol Gastroenterol (Paris); 1974; 7(2):101-10. PubMed ID: 4451683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostaglandins and insulin secretion : effect indomethacin on the serum insulin response to glucagon in man].
    Bertolini S; Castello C; Jacopino GE; Pistocchi G; Elicio N; Balestreri R
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1576-82. PubMed ID: 192255
    [No Abstract]   [Full Text] [Related]  

  • 20. Measuring the effect of a study meal on portal concentrations of glucagon-like peptide 1 (GLP-1) in non diabetic and diabetic patients with liver cirrhosis: transjugular intrahepatic portosystemic stent shunt (TIPSS) as a new method for metabolic measurements.
    Raddatz D; Nolte W; Rossbach C; Leonhardt U; Buchwald A; Scholz KH; Ramadori G
    Exp Clin Endocrinol Diabetes; 2008 Aug; 116(8):461-7. PubMed ID: 18770489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.